Search results
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
Zacks via Yahoo Finance· 7 months agoAbbVie (ABBV) offers to buy ImmunoGen (IMGN) for approximately $10.1 billion, which will diversify...
Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio
Associated Press via AOL· 7 months agoAbbVie will pay around $10 billion to add a potential blockbuster cancer treatment as cheaper...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 7 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
Motley Fool via Yahoo Finance· 6 months agoDrug patents don't last forever, so pharmaceutical companies are constantly looking for the next big...
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
Investor's Business Daily· 7 months agoAbbVie has agreed to buy ImmunoGen for $10.1 billion in cash, offering a rich premium for the maker...
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
Motley Fool· 6 months agoAbbVie's share price reflected the concerns. AbbVie's executives and business development team have...
AbbVie seeks lift from 'guided missile' cancer drug with $10 billion ImmunoGen deal
Reuters via Yahoo Finance· 7 months ago(Reuters) -AbbVie will buy ImmunoGen for $10.1 billion in cash, it said on Thursday, the latest...
AbbVie signs $10 billion deal to buy cancer drugmaker ImmunoGen
Reuters via Yahoo Finance· 7 months agoThe deal, which prices ImmunoGen's stock at a 95% premium, could boost AbbVie's plans to expand into...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 months agoAbbVie's acquisition of ImmunoGen strengthens its oncology pipeline and solid tumor capabilities. Robust financial performance with $12.3 billion in net...
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
Motley Fool via Yahoo Finance· 6 months agoWith AbbVie (NYSE: ABBV) reporting on Nov. 30 that it plans to acquire ImmunoGen, (NASDAQ: IMGN) a...